Skip to content

Clinical effect of electroacupuncture on regulating sperm motility in patients with asthenospermia

Clinical effect and mechanism of electroacupuncture on regulating sperm motility in patients with asthenospermia

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004698
Enrollment
Unknown
Registered
2021-04-06
Start date
2021-04-20
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male infertility

Interventions

Electroacupuncture Group:Electroacupuncture

Sponsors

Seventh People's Hospital, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
22 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1.Male aged 20 to 50 years; 2.The couple have lived together for more than one year after marriage, no contraceptive measures have been taken, female infertility due to male reasons; The male examination met the diagnostic criteria of male asthenospermia; 3.It conforms to the classification standard of "kidney yang deficiency syndrome" in TCM syndrome differentiation; 4.The sexual function was normal without other organic lesions of reproductive system; 5.Patients signed informed consent and participate voluntarily.

Exclusion criteria

Exclusion criteria: 1.Patients with azoospermia and oligospermia; 2.Patients with congenital malformation, vascularis ovstruction, testicular atrophy, varicocele degree II or above; 3.Patients with mental or other similar diseases; 4.Any serious psychological abnormality that cannot be well controlled; 5.History of reproductive system surgery, trauma, or organic lesions; 6.The spouse has serious gynecological diseases and cannot rule out the influence on fertility; 7.Regular and unprotected sex life is less than 1 time /2 months or erectile dysfunction, abnormal ejaculation; 8.Patients who take drugs that hinder spermatogenesis and sperm motility, such as anti-epilepsy and anti-tumor; 9.Patients with severe primary diseases such as cardiovascular, liver, kidney and hematopoietic system; 10.Patients received acupuncture or other non-drugs or drugs for asthenospermia within 3 months; 11.Patients with skin damage at acupoints.

Design outcomes

Primary

MeasureTime frame
Total clinical efficacy;Routine semen analysis;

Secondary

MeasureTime frame
Classification and quantification table of clinical symptoms of Traditional Chinese Medicine;

Countries

China

Contacts

Public ContactHan Wenjun

Seventh People's Hospital, Shanghai University of Traditional Chinese Medicine

hwj-han@163.com+86 13636556810

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026